Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...
When treated early, Stage 1 lung cancer patients have a five-year survival rate of above 70 per cent. Read more at straitstimes.com. Read more at straitstimes.com.
The Food and Drug Administration (FDA) granted traditional approval to Imdelltra (tarlatamab-dlle) for adult patients with ...
Researchers at Northwestern Medicine found that 65% of their lung cancer patients weren't eligible for screening. They were ...
Breast cancer may be more treatable than many other cancers, however, even their treatability depends on how early they are ...
Giredestrant significantly improves IDFS in ER-positive, HER2-negative early-stage breast cancer, surpassing standard ...
LCMC Health is committed to reducing cancer rates throughout Louisiana. In recent months, the system has placed an emphasis ...
A NEW prostate cancer trial is being rolled out on the NHS, aiming to find the best screening techniques to catch the deadly ...